Charter Communications Revises Buyout Offer for Liberty Broadband at Improved Terms Biogen Completes 53 Billion Acquisition of Apellis Pharmaceuticals Megacap Tech IPOs Force Index Providers to Rethink Inclusion Rules Gen Z Homeownership Defies Odds Young Buyers Outpace Millennials at Same Age June Quarter Earnings Could Determine Market Direction Says Analyst NearTerm Risks Highlighted Government of Andhra Pradesh and foundit Partner to Boost Employment and Skill Development Nvidias Market Cap Surpasses Six of the Worlds Top 10 Stock Markets Amid AIDriven Surge Wholesale Inflation Accelerates Producer Price Index Surges 6 Annually in April Largest Gain Since 2022 OpenAI Gains Early Advantage in AI IPO Race as Confidential Filing Reports Emerge Jim Cramer Praises Xometrys Growth Trajectory on Recent Show MTNB Q4 2024 Earnings Narrowed Loss Surpasses Expectations Pipeline Momentum Continues EXAS Q4 2025 Earnings Significant EPS Miss Amidst Challenging Quarter MDCX Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Posts WiderthanExpected Loss SIGA Q1 2026 Earnings Net Loss of 005 per Share as Revenue Figures Remain Undisclosed BHFAL Q1 2026 Earnings Missed EPS Estimates Amid Challenging Interest Rate Environment CREG Q1 2026 Earnings Loss per Share of 003 as Company Continues Strategic Transition Workday Inc WDAY Surges 516 as Buyers Test Key Resistance Level Owlet Inc OWLT Holds Steady at 573 as Consolidation Narrows the Trading Range Aclarion Inc ACON Surges Over 6 as Shares Test Key Resistance Near 350 Nomura Holdings NMR Slips 136 as Support Test Looms Gaxosai Inc GXAI Slips 345 as Support at 106 Looms Potential Bounce or Further Weakness Roivant Sciences ROIV Edges Lower Amid Consolidation Near Resistance Levels PDF Solutions Surges 527 as Shares Test Key Resistance Levels Sidus Space SIDU Surges 24 Breaking Above Key Resistance Levels Tillys Inc TLYS Shows Early Signs of Recovery as Shares Bounce from Support ON24 Inc ONTF Hovers Near 810 as Modest Gain Hints at Stabilization Standard Chartered to Cut Over 15 of Corporate Functions Roles in Pursuit of Higher Returns SPMC Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction Acrivon Therapeutics ACRV Narrows Lower as Biotech Sentiment Remains Cautious